Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bladou

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23W J Ellis, R L Vessella, K R Buhler, et al.
European Journal of Cancer Care|August 28, 2009
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticatorsJ-L Deville, G Gravis, N Salem, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 10, 2021
[Prostatic Urethral Lift under local anesthesia: Single-centre retrospective observational study]L Dupitout, F Bladou, J-C Bernhard, et al.
Annales De Pathologie|April 4, 1998
[Clear cell sarcoma of the kidney relapsing after 10 years of asymptomatic evolution]E Charafe, F Penault-Llorca, M P Mathoulin-Portier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 3, 2020
[Predictive factors of active surveillance interruption for prostate cancer after 5years of follow-up]J-P Le Paih, F Bladou, C Klein, et al.
The Journal of Urology|October 24, 2002
Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer riskJ Irani, V Ravery, J L Pariente, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 1, 2014
[Head to head comparison of two currently used nomograms predicting the risk of side specific extra capsular extension to indicate nerve sparing during radical prostatectomy for treatment of prostate cancer]C Clement, C Maurin, J Villeret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?R Sabatier, J C Eymard, J Walz, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 29, 2020
Active surveillance in prostate cancer is possible for Afro-Caribbean population: Comparison of oncological outcomes with a Caucasian cohortM Percot, G Robert, F Bladou, et al.
Oncogene|January 27, 2010
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4EC Andrieu, D Taieb, V Baylot, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23W J Ellis, R L Vessella, K R Buhler, et al.
European Journal of Cancer Care|August 28, 2009
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticatorsJ-L Deville, G Gravis, N Salem, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 10, 2021
[Prostatic Urethral Lift under local anesthesia: Single-centre retrospective observational study]L Dupitout, F Bladou, J-C Bernhard, et al.
Annales De Pathologie|April 4, 1998
[Clear cell sarcoma of the kidney relapsing after 10 years of asymptomatic evolution]E Charafe, F Penault-Llorca, M P Mathoulin-Portier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 3, 2020
[Predictive factors of active surveillance interruption for prostate cancer after 5years of follow-up]J-P Le Paih, F Bladou, C Klein, et al.
The Journal of Urology|October 24, 2002
Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer riskJ Irani, V Ravery, J L Pariente, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 1, 2014
[Head to head comparison of two currently used nomograms predicting the risk of side specific extra capsular extension to indicate nerve sparing during radical prostatectomy for treatment of prostate cancer]C Clement, C Maurin, J Villeret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?R Sabatier, J C Eymard, J Walz, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 29, 2020
Active surveillance in prostate cancer is possible for Afro-Caribbean population: Comparison of oncological outcomes with a Caucasian cohortM Percot, G Robert, F Bladou, et al.
Oncogene|January 27, 2010
Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4EC Andrieu, D Taieb, V Baylot, et al.
Pageof 7